Abstract
In 2018, the Severe Asthma team at Wythenshawe Hospital assessed adherence to preventer inhalers in long-tern omalizumab patients and found that 50.6% of patients were non-adherent (1). In response, service...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
